Jun 20, 2025 | Advocacy, Federal Guidelines, Position Papers
AAHKS has developed a library of position statements as expressions of the association’s views on important subjects in arthroplasty, such as opioid use for the treatment of osteoarthritis, CDC guidelines on the use of antibiotics and removal of TKA from CMS’s...
Jul 12, 2024 | Committees and Task Forces, Performance Measures, Position Papers, Practice Management, Publications
Thanks to volunteer surgeons offering their time and expertise, many practice management and patient education resources are available for members to use in their practices every day. This practical information includes clinical practice guidelines, coding resources,...
Jan 12, 2023 | Position Papers
Addressing a high-priority AAHKS advocacy issue, the Federal Trade Commission (FTC) released a proposed rule to eliminate non-compete clauses. Under the proposed rule, all post-employment non-compete clauses would be considered an unfair method of competition and...
Jun 27, 2019 | Patient Education, Position Papers, Website
A special task-force collaboration by AAHKS members Stefano A. Bini, MD, Craig J. Della Valle, MD, Mark I. Froimson, MD, Charles P. Hannon, MD and Brett R. Levine, MD has produced a comprehensive source of education to address the opioid epidemic in the United States....
Jun 27, 2019 | In the News, Position Papers
Time reported last week that grocery chain, Hy-Vee, has contracted with stem cell company, Regenexx, to provide stem cell treatments to employees who are experiencing knee pain. Hy-Vee is requiring that employees take the stem cell therapy route before they can seek...
May 16, 2019 | In the News, Patient Education, Position Papers
The New York Times reported this week on “rogue clinics” offering stem cell and platelet rich plasma (PRP) as treatment for osteoarthritis pain. The US Food and Drug Administration, the company Regenexx and a number of researchers were interviewed for the article,...
